Detail

Study ID: COG AALL1731

Title:

A Phase 3 Trial Investigating Blinatumomab (IND# 117464, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma (B-LLy)

Location:
Fargo Region, Sioux Falls Region
Principal Investigator:
Kayelyn Wagner, MD,Samuel Anim, MD
Disease:
ALL (Acute Lymphocytic Leukemia)
Stage:
Phase III
Status:
Active - Open to Accrual